Report - Orphan diseases - KAMADA INVESTOR … Presentation 9 2016.pdf4. Safe and tolerable drug Kamada submitted MAA in March 2016 on the basis of: 1. Orphan designated drug 2. Demonstrated

Please pass captcha verification before submit form